Title
A new approach for pyrazinamide susceptibility testing in mycobacterium tuberculosis
Date Issued
01 August 2012
Access level
open access
Resource Type
journal article
Publisher(s)
Mary Ann Liebert
Abstract
Background: Pyrazinamide (PZA) is an important drug in the treatment of tuberculosis. Microbiological methods of PZA susceptibility testing are controversial and have low reproducibility. After conversion of PZA into pyrazinoic acid (POA) by the bacterial pyrazinamidase enzyme, the drug is expelled from the bacteria by an efflux pump. Objective: To evaluate the rate of POA extrusion from Mycobacterium tuberculosis as a parameter to detect PZA resistance. Methods: The rate of POA extrusion and PZA susceptibility determined by BACTEC 460 were measured for 34 strains in a previous study. PZA resistance was modeled in a logistic regression with the pyrazinoic efflux rate. Result: POA efflux rate predicted PZA resistance with 70.83%-92.85% sensitivity and 100% specificity compared with BACTEC 460. Conclusion: POA efflux rate could be a useful tool for predicting PZA resistance in M. tuberculosis. Further exploration of this approach may lead to the development of new tools for diagnosing PZA resistance, which may be of public health importance. © 2012 Mary Ann Liebert, Inc.
Start page
372
End page
375
Volume
18
Issue
4
Language
English
OCDE Knowledge area
Sistema respiratorio Enfermedades infecciosas
Scopus EID
2-s2.0-84864329441
PubMed ID
Source
Microbial Drug Resistance
ISSN of the container
19318448
Sponsor(s)
Fogarty International Center D43TW006581 FIC
Sources of information: Directorio de Producción Científica Scopus